BackPJSC Ozon Pharmaceuticals Overview

PJSC Ozon Pharmaceuticals Receivables

Track PJSC Ozon Pharmaceuticals's receivables ($13B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$12.56B
↑ 26.65% YoYΔ $2.64B vs prior year quarter

Peer trimmed avg / median

Loading

PJSC Ozon Pharmaceuticals Receivables History

Loading

PJSC Ozon Pharmaceuticals vs. peers: Receivables Comparison

Loading

PJSC Ozon Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PJSC Ozon Pharmaceuticals (OZPH.ME) FAQ

PJSC Ozon Pharmaceuticals (OZPH.ME) currently reports a receivables of $13B as of June 2026. That compares with $9.9B in the prior-year period — up 26.7% year over year. Use the charts on this page to explore PJSC Ozon Pharmaceuticals's receivables history and peer comparisons.

PJSC Ozon Pharmaceuticals's receivables increased from $9.9B to $13B — a 26.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PJSC Ozon Pharmaceuticals reported $13B in receivables as of June 2026. That compares with $9.9B in the prior-year period — up 26.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $13B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PJSC Ozon Pharmaceuticals, and consider following OZPH.ME for alerts when major investors trade the stock.